Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

536
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
536
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

9.6K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.6K
Chromosome Replication02:31

Chromosome Replication

10.5K
Before a cell can divide, it must accurately replicate all of its chromosomes, including the DNA and its associated histone and non-histone proteins.  This process begins at numerous origins of replication during the S phase of the cell cycle in each of a cell’s chromosomes simultaneously. Certain nucleotides can act as origins of replication, but these sequences are not well defined - especially in complex, multi-cellular, eukaryotic species. The length of DNA that spans an origin...
10.5K
Replication in Prokaryotes02:35

Replication in Prokaryotes

97.4K
Overview
97.4K
Long-term Depression01:05

Long-term Depression

33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
DNA Replication02:40

DNA Replication

58.9K
DNA replication involves the separation of the two strands of the double helix, with each strand serving as a template from which the new complementary strand is copied.  After replication, each double-stranded DNA includes one parental or “old” strand and one “new” strand. This is known as semiconservative replication. The resulting DNA molecules have the same sequence and are divided equally into the two daughter cells.
Replication in Prokaryotes
DNA replication...
58.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker affliction classes contribute additively to observed dementia severity and prospective conversion risk.

Journal of Alzheimer's disease : JAD·2026
Same author

Chemical Intolerance Is Associated with Autism Spectrum and Attention Deficit Disorders: A Five-Country Cross-National Replication Analysis.

Journal of xenobiotics·2026
Same author

Affliction class moderates the impact of neurodegeneration: Implications for A/T/N.

Journal of Alzheimer's disease : JAD·2025
Same author

Affliction class moderates the dementing impact of amyloidopathy.

Neuropsychology·2025
Same author

Effects of the COVID-19 pandemic on individuals with chemical intolerance.

Family medicine and community health·2025
Same author

Affliction class moderates the dementing impact of adipokines.

Neuropsychology·2024

Related Experiment Video

Updated: Jan 24, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K

Selection for depression-specific dementia cases with replication in two cohorts.

Donald R Royall1,2,3,4, Raymond F Palmer3,

  • 1Department of Psychiatry, the University of Texas Health Science Center, San Antonio, Texas, United States of America.

Plos One
|June 1, 2019
PubMed
Summary

Depression significantly predicts dementia severity (δ), with resistin levels partially explaining this link. This research identifies individuals whose dementia may stem from depression, offering potential for reversible treatment.

More Related Videos

Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System
11:19

Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System

Published on: August 21, 2016

9.5K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

Related Experiment Videos

Last Updated: Jan 24, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K
Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System
11:19

Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System

Published on: August 21, 2016

9.5K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.8K

Area of Science:

  • Neurology
  • Biomarkers
  • Gerontology

Background:

  • Dementia severity is often assessed using omnibus metrics, but their etiological specificity can be limited.
  • Depressive symptoms are increasingly recognized as potential contributors to cognitive decline and dementia.
  • The relationship between depression, dementia severity, and specific biomarkers like resistin requires further elucidation.

Purpose of the Study:

  • To introduce an etiologically agnostic dementia severity metric (δ) capable of identifying the dementing potential of various conditions.
  • To investigate depressive symptoms as independent predictors of dementia severity (δ).
  • To explore the mediating role of serum resistin levels in the association between depressive symptoms and dementia severity.

Main Methods:

  • Utilized a novel "off-diagonal" CHI SQ algorithm for statistical analysis.
  • Applied the algorithm to large cohorts: Texas Alzheimer's Research and Care Consortium (TARCC) and Alzheimer's Disease Neuroimaging Initiative (ADNI).
  • Selected individuals exhibiting dementia solely attributable to depression's effects and analyzed their resistin levels.

Main Results:

  • Successfully identified individuals with depression-induced dementia in both TARCC and ADNI cohorts.
  • Demonstrated that depressive symptoms are independent predictors of dementia severity (δ).
  • Observed higher serum resistin levels in individuals with depression-induced dementia within the TARCC cohort, suggesting a partial mediating role.

Conclusions:

  • The developed metric (δ) and analytical approach can identify dementia driven by specific factors like depression.
  • Serum resistin partially mediates the link between depressive symptoms and dementia severity.
  • This methodology can be adapted to other dementia risk factors and biomarkers, potentially identifying individuals eligible for treatments aimed at reversing cognitive decline.